PacBio and Covaris have launched a new joint workflow for high-accuracy HiFi sequencing from FFPE tumor samples. Unlock archived tissue with over 100M HiFi reads and 11k+ structural variants per sample.

Get up to speed before #AACR26: bit.ly/4cf1RfW

#PacBio #OncologyResearch #CancerGenomics

Published by: Yang Du, Pei Zhang, Wei Liu, et al. 👥
📅 Published on: February 7, 2022
📄 Full Study: [DOI: 10.1007/s43657-021-00041-y] 🔗
#Epigenetics #CancerImaging #OpticalImaging #PrecisionMedicine #OncologyResearch

We are looking to build on the positive initial results evaluating our first-in-class MYB RNA degrader, REM-422, in patients with recurrent or metastatic ACC. Our Phase 1/2 clinical trial is open and enrolling, learn more here: bit.ly/4oXyim2
#REM-422 #AdeonoidCysticCarcinoma #OncologyResearch

How mRNA and Neoantigen Technologies Are Transforming the Cancer... Cancer immunotherapy has significantly transformed the treatment landscape by introducing innovative approaches that leverage the body’s immune system to fight malignant cells. Among these, cancer vac...

How mRNA and Neoantigen Technologies Are Transforming the Cancer Vaccines Market

Source: www.panchit.com/blogs/5068/H...

#CancerVaccines #OncologyResearch #Immunotherapy #CancerTreatment

CSI Singapore Director, Prof. Ashok Venkitaraman reflects on discoveries in genome stability and the BRCA2 gene, and how translational platforms can move insights from lab to clinic.

Watch here: youtube.com/watch?v=KxWP...

#genomestability #BRCA2 #cancerresearch #oncologyresearch

This commentary proposes a stratified sequential strategy that preserves Fecal Immunochemical Test based efficiency while using liquid biopsy only to rescue persistent non-responders.
doi.org/10.59717/j.x...
#OncologyResearch #liquidbiopsy #ColorectalCancer

Full interview → youtu.be/sy27JEDNE98

#EUSABV #SABVinAction #ScientificRigor #OncologyResearch #OpenScience #ResearchLeadership
@costprogramme.bsky.social

The Surprising Reason Cancer Treatments Don’t Work for Everyone A new study sheds light on why promising cancer treatments can produce dramatically different results across patients.

The Surprising Reason Cancer Treatments Don’t Work for Everyone #Science #HealthandMedicine #Oncology #CancerResearch #PersonalizedMedicine #OncologyResearch

scitechdaily.com/the-surprising-reason-ca...

Early laboratory results show about 50% of targeted cancer cells destroyed while 99% of healthy cells remained unharmed. Targeted delivery like this could dramatically reduce treatment side effects. #OncologyResearch #TCSC

Paclitaxel is widely used but notoriously difficult to deliver effectively. Innovative delivery systems could help concentrate the drug at tumors while sparing healthy tissue. #OncologyResearch #TCSC

🚨 Last Date for Registration – Don’t Miss Out!
11th International Congress on Cancer Science and Radiology 2026.
📅 Date: July 22–23, 2026
📍 Venue: Hilton Tokyo Hotel
Email: cancertherapy@inovineconferences.com

#cancerconference #cancerscience #oncologyresearch

#cancer #cancermetabolism #metabolism #TumourMetabolism #OncologyResearch #ACMM2026

The KEYNOTE-B96 trial reported an improvement in overall survival and progression-free survival, marking one of the most promising advances for patients with platinum-resistant ovarian cancer.

#CancerBreakthrough #OncologyResearch #HopeInScience #TCSC

Up to 75% of patients report cognitive issues during chemotherapy. Studies like this show supportive care matters just as much as drugs. Exercise may become part of routine cancer care in the future.

#CancerCare #CancerTreatment #OncologyResearch #TCSC

The National Training Day 2026 report is now available. The event brought together trainees and investigators from across Ireland to share research, discuss multidisciplinary collaboration, and reflect on the future of cancer trials.

Read the report: bit.ly/4ro56FZ

#CancerTrials #OncologyResearch

Triple-negative breast cancer remains one of the toughest cancers to treat. Discoveries like this could open the door to entirely new therapies. #OncologyResearch #PrecisionMedicine #TCSC

Breast Cancer Congress 2026
📍 Barcelona, Spain
📅 5–6 November 2026

Join researchers and clinicians advancing breast cancer research and precision oncology.

Submit your abstract:
pinkribboncongress.com/abstract-sub...

#BreastCancer #OncologyResearch

Last call to apply for @conquercancer.bsky.social CDA in Triple Negative #BreastCancer! Secure funding to support your clinical #OncologyResearch career. Applications due March 12. U.S. applicants only.

Apply now & advance your career in #TNBC research: https://bit.ly/40vua2K
#OncologyResearch

🌍 11th International Congress on Cancer Science and Radiology 2026
📅 July 22–23, 2026
📍 Hilton Tokyo Hotel
🌐 Website: cancertherapy.inovineconferences.com
📧 Email: cancertherapy@inovineconferences.com

#cancerscience2026 #radiologyconference #oncologyresearch

ONCOLOGY NEWS: Could household cats hold the key to understanding breast cancer? Read the story here: t.ly/F3aqV #Cat #BreastCancer #CancerResearch #OncologyResearch #BreastResearch

ONCOLOGY NEWS: Can AI improve the accuracy of identifying patients eligible for oncology clinical trials? Explore new research: t.ly/Jo5N3 #AI #ArtificalIntelligence #OncologyResearch #OncologyClinicalTrials #CancerTrials #CancerResearch #TrialParticipantSelection

We’re excited to unveil IDT’s latest #NGS innovation roadmap—purpose-built to accelerate cancer breakthroughs and empower researchers working at the forefront of precision #oncologyresearch. 👏

Read more here: idtb.io/pa7j4h

#cancerresearch #precisiononcology #precisionhealth

Humolyte® with 2’-Fucosyllactose and Magnesium Shows Promise in Reducing Chemotherapy-Induced Mucositis — HuMOLYTE A preclinical study submitted for peer review found that Humolyte®, a medical food containing 2’-fucosyllactose (2’-FL) and magnesium, reduced chemotherapy-induced mucositis, diarrhea, and weight loss...

Chemotherapy-induced mucositis can be painful and debilitating—but new research offers hope.

www.humolyte.com/blog/humolyt...

#ChemotherapySupport #Mucositis #CancerCare #GutHealth #OncologyResearch

#MRD assessment and #MCED are transforming #cancercare strategies. Learn more about how IDT’s advanced #NGS solutions are powering the research behind this progress: idtb.io/xtkf2o

#cancerresearch #oncologyresearch

🔬 Thank you to Professor Jonathan Higgins for an excellent #NUCancer Seminar on “Dicentric Chromosomes, Genome Instability, and Cancer.”
Great discussions and insights into chromosome rearrangements and cancer biology.

#CancerResearch #NewcastleUniversity #OncologyResearch

Not just 'what' treatment, but 'when'? The emerging role of chrono-oncology: t.ly/lukx2
Earlier-day immunochemotherapy delivery may be associated with improved outcomes in advanced NSCLC

#LungCancer #NSCLC #Immunotherapy #Chemotherapy #Oncology #OncologyResearch #OncologyNews #CanSky #MedSky

Discovery of Niclosamide Analogs with Potent Mitochondrial Uncoupling Activity and Reduced Mitochondrial Inhibition–Associated Toxicity Niclosamide, an FDA-approved anthelmintic, functions as a mitochondrial uncoupler with promising anticancer potential, yet its efficacy remains limited, often ascribed to poor bioavailability. We iden...

Discovery of Niclosamide Analogs with Potent Mitochondrial Uncoupling Activity and Reduced Mitochondrial Inhibition–Associated Toxicity
pubs.acs.org/doi/10.1021/...

#KellyChibale #MedicinalChemistry #CancerResearch #MitochondrialBiology #OncologyResearch #DrugDiscovery #QSAR

Lung cancer in ‘never-smokers’ draws new focus — and questions In the United States and elsewhere, there’s been a major shift in patients treated for lung cancer.

Lung cancer in ‘never-smokers’ draws new focus — and questions

statnews.com/2026/02/11/l...

#LungCancer #NeverSmokers #LungCancerAwareness #CancerResearch #ThoracicOncology#PrecisionMedicine #TargetedTherapy #EnvironmentalHealth #AirPollution #PublicHealth #CancerPrevention #OncologyResearch

Yesterday, CSI Singapore hosted Dr. Olufunmilayo Olopade from The University of Chicago. She spoke on the topic “Heterogeneity of Breast Cancer Genomes in Diverse Populations”.

#precisionmedicine #breastcancerresearch #cancergenomics #genomicmedicine #cancerresearch #cancerscience #oncologyresearch

Atebimetinib Signals a Potential Shift in First-Line Pancreatic Cancer Outcomes | Pharmacy Times Experts discuss groundbreaking data on pancreatic cancer treatment, revealing a 64% survival rate and its potential to transform patient care and outcomes.

SCRI and SCRI Oncology expert, Dr. Meredith Pelster joined Pharmacy Times to discuss emerging data that could meaningfully change the treatment landscape for pancreatic cancer. Watch below to learn more:
www.pharmacytimes.com/view/atebime...
#PancreaticCancer #SCRI #OncologyResearch